Clinical Trials Directory

Trials / Completed

CompletedNCT00081627

Clinical Trial in Patients With Metastatic Colorectal Cancer

COFU: A Multi-Center Phase II Clinical Trial to Evaluate the Safety and Efficacy of Weekly Treatment With CoFactor and 5-Fluorouracil in Patients With Metastatic Colorectal Carcinoma

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
48 (planned)
Sponsor
Mast Therapeutics, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objectives of this trial are to determine if CoFactor in combination with 5-FU are effective in the treatment of metastatic colorectal cancer and to determine the side effects observed with the administration of CoFactor and 5-FU.

Conditions

Interventions

TypeNameDescription
DRUGCoFactor and 5FU

Timeline

Start date
2004-04-01
Completion
2007-01-01
First posted
2004-10-14
Last updated
2007-11-27

Locations

9 sites across 2 countries: United States, Serbia and Montenegro

Source: ClinicalTrials.gov record NCT00081627. Inclusion in this directory is not an endorsement.